JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue1,618,6931,487,9731,324,803
Cost of Revenue110,188105,386102,526
Gross Profit1,508,5051,382,5871,222,277
Operating Expenses
Research Development198,442162,297135,253
Selling General and Administrative544,156502,892449,119
Non Recurring85,00023,75031,523
Others152,065101,99498,162
Total Operating Expenses979,663790,933714,057
Operating Income or Loss528,842591,654508,220
Income from Continuing Operations
Total Other Income/Expenses Net-9,9692,734-15,370
Earnings Before Interest and Taxes518,873595,026509,665
Interest Expense77,75661,94256,917
Income Before Tax441,117533,084452,748
Income Tax Expense-47,740135,236106,399
Minority Interest---
Net Income From Continuing Ops487,848396,831329,535
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income487,848396,831329,535
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares487,848396,831329,535